AR044065A1 - Procedimiento para preparar nicotinaldehidos, sustancias de partida para dicho procedimiento y el uso de morfolinamidas del acido nicotinico para la preparacion de los nicotinaldehidos correspondientes - Google Patents

Procedimiento para preparar nicotinaldehidos, sustancias de partida para dicho procedimiento y el uso de morfolinamidas del acido nicotinico para la preparacion de los nicotinaldehidos correspondientes

Info

Publication number
AR044065A1
AR044065A1 ARP040101376A ARP040101376A AR044065A1 AR 044065 A1 AR044065 A1 AR 044065A1 AR P040101376 A ARP040101376 A AR P040101376A AR P040101376 A ARP040101376 A AR P040101376A AR 044065 A1 AR044065 A1 AR 044065A1
Authority
AR
Argentina
Prior art keywords
nicotinic acid
procedure
nicotinaldehydes
starting substances
hal
Prior art date
Application number
ARP040101376A
Other languages
English (en)
Inventor
Mike Brandner
Ludwig Gantzert
Ralf Knierieme
Bokel Heinz-Hermann Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR044065A1 publication Critical patent/AR044065A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/48Aldehydo radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describe un procedimiento para la preparación reductiva de nicotinaldehídos que en calidad de sustancias de partida para la reducción emplea las correspondientes morfolinamidas del ácido nicotínico. Dichas morfolinamidas de ácido nicotínico responden preferentemente a la fórmula (1), en la que: R1', R1'' representan independientemente H, Hal, A, OA, CH2R2 o Ar; R2 representa OA o NA2; A representa alquilo de cadena recta o ramificada y de C1-10, en donde uno o dos grupos CH2 pueden estar reemplazados por átomos de O o S y/o por grupos -CH=CH y/o también 1 a 7 átomos de H pueden estar reemplazados por F; Ar representa un sistema homo o heterocíclico con los heteroátomos O, N, S, de uno o más núcleos, insaturado, parcialmente o totalmente saturado, no sustituido o mono o polisustituido con Hal A, OA, NA2, NO2, NASO2A, SO2NA, SO2A; y Hal representa F, Cl, Br o I. También se describen el uso de morfolinamidas del ácido nicotínico y las sustancias de partida para el procedimiento mencionado más arriba. Este procedimiento permite obtener aldehídos del ácido nicotínico con rendimientos casi cuantitativos por reducción en condiciones normales (temperatura ambiente y sin presión).
ARP040101376A 2003-04-24 2004-04-23 Procedimiento para preparar nicotinaldehidos, sustancias de partida para dicho procedimiento y el uso de morfolinamidas del acido nicotinico para la preparacion de los nicotinaldehidos correspondientes AR044065A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10318690A DE10318690B3 (de) 2003-04-24 2003-04-24 Verfahren zur Herstellung von Nicotinaldehyden

Publications (1)

Publication Number Publication Date
AR044065A1 true AR044065A1 (es) 2005-08-24

Family

ID=33154397

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101376A AR044065A1 (es) 2003-04-24 2004-04-23 Procedimiento para preparar nicotinaldehidos, sustancias de partida para dicho procedimiento y el uso de morfolinamidas del acido nicotinico para la preparacion de los nicotinaldehidos correspondientes

Country Status (16)

Country Link
US (1) US7528256B2 (es)
EP (1) EP1615891B1 (es)
JP (1) JP2006524196A (es)
KR (1) KR101106621B1 (es)
CN (1) CN100355730C (es)
AR (1) AR044065A1 (es)
AU (1) AU2004232454B2 (es)
BR (1) BRPI0409644B1 (es)
CA (1) CA2523190C (es)
DE (1) DE10318690B3 (es)
ES (1) ES2426412T3 (es)
HK (1) HK1087111A1 (es)
MX (1) MXPA05011253A (es)
RU (1) RU2339619C2 (es)
WO (1) WO2004094383A1 (es)
ZA (1) ZA200509495B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5807955B2 (ja) * 2011-12-15 2015-11-10 国立大学法人横浜国立大学 植物用抵抗性誘導剤、植物の抵抗性誘導方法、及び植物病害の予防方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
US6521618B2 (en) * 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
AR035851A1 (es) * 2000-03-28 2004-07-21 Wyeth Corp 3-cianoquinolinas, 3-ciano-1,6-naftiridinas y 3-ciano-1,7-naftiridinas como inhibidoras de proteina quinasas
SI1427724T1 (sl) * 2001-09-19 2006-10-31 Merck Patent Gmbh Nova uporaba substituiranih aminometil-kromanov

Also Published As

Publication number Publication date
ZA200509495B (en) 2009-03-25
AU2004232454B2 (en) 2010-02-25
CA2523190A1 (en) 2004-11-04
AU2004232454A1 (en) 2004-11-04
EP1615891A1 (de) 2006-01-18
EP1615891B1 (de) 2013-06-19
KR101106621B1 (ko) 2012-01-20
CA2523190C (en) 2012-01-24
CN100355730C (zh) 2007-12-19
US20060199965A1 (en) 2006-09-07
KR20060006056A (ko) 2006-01-18
BRPI0409644B1 (pt) 2019-01-22
RU2339619C2 (ru) 2008-11-27
ES2426412T3 (es) 2013-10-23
JP2006524196A (ja) 2006-10-26
DE10318690B3 (de) 2004-11-11
RU2005136382A (ru) 2006-06-10
US7528256B2 (en) 2009-05-05
WO2004094383A1 (de) 2004-11-04
BRPI0409644A (pt) 2006-04-25
CN1777587A (zh) 2006-05-24
MXPA05011253A (es) 2005-12-14
HK1087111A1 (en) 2006-10-06

Similar Documents

Publication Publication Date Title
AU2018287777B2 (en) SSAO inhibitor
AR068054A1 (es) Compuestos de pirrolopirimidina
AR048495A1 (es) Benzoil amino heterociclicos, utiles para el tratamiento de enfermadades intermediadas por glk
CO5650227A2 (es) Derivados del acido propionico utiles en desordenes lipidicos
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
AR057705A1 (es) 3-acilaminobenzanilidas insecticidas
PE20081806A1 (es) Imidazo- y triazolopirimidinas sustituidas
AR002241A1 (es) Derivado de 2,4-oxazolidinadiona, composicion farmaceutica que lo comprende y metodo de preparacion del mismo.
ES2136103T3 (es) Procedimiento para la preparacion de derivados de estaurosporina.
AR050155A1 (es) 3-aminoindazoles, un procedimiento de preparcion, uso de los compuestos para preparar medicamentos, dichos medicamentos y un compuesto intermediario
RU2001123126A (ru) Производные пиридопираноазепинов, их получение и терапевтическое применение
ES2928961T3 (es) Compuestos novedosos para controlar artrópodos
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
AR050154A1 (es) Derivados de acido butanoico, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden
NO20055150L (no) Benzotiazolderivater som adenosin-reseptorligander
US2401522A (en) Aromatic carboxylic acid amides and a process for their manufacture
AR044065A1 (es) Procedimiento para preparar nicotinaldehidos, sustancias de partida para dicho procedimiento y el uso de morfolinamidas del acido nicotinico para la preparacion de los nicotinaldehidos correspondientes
EA200970497A1 (ru) Производные пиррола, их получение и их применение в терапии
ES2032335T3 (es) Nuevos derivados flavonoides 2-piperazinil-2-oxo-etilen sustituidos, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR048716A1 (es) Derivados de acido pentenoico, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden y sus aplicaciones terapeuticas
ES2561879T3 (es) Derivados de piridilbenzoxazina, composición farmacéutica que comprende los mismos y uso de los mismos
AR074629A1 (es) Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2
BR112021024039A2 (pt) Sínteses de furanos substituídos
CL2004000978A1 (es) Compuestos derivados de pirazolopirimidinas sustituidos de formula definida, inhibidores de pde; procedimiento para su preparacion; composicion farmaceutica que los contiene y sus usos para preparar medicamentos que sirven para tratar trastornos de l
CN113549043B (zh) 一种黄酮类端锚聚合酶2抑制剂及其制备方法和应用

Legal Events

Date Code Title Description
FB Suspension of granting procedure